ClinicalTrials.gov
public full text
Public Domain
Cryoablation Combined With Sintilimab Plus Lenvatinib in 1L Treatment of Advanced ICC (CASTLE-ICC-Chemo-free)
The objective of this study is to evaluate the efficacy and safety of cryoablation combined with Sintilimab plus lenvatinib as first-line treatment in patients with advanced ICC.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Cryoablation Combined with Sintilimab Plus Regorafenib in Previously Treated Colorectal Cancer Liver Metastasis#1095877
- Clinical Study of Targeted Cryoablation Therapy in the Treatment of Hepatic Carcinoma#1087429
- Cryoablation combined with immunotherapy: new strategies and progress in the treatment of tumors.#613443
- Cryoablation Combined With PD-1 Antibody and Bevacizumab for Hepatocellular Carcinoma#969602
- Efficacy, Safety and Tolerability of Sexelaxin When Added to Standard Therapy in AHF#915586
Record · ID 825792
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive